Literature DB >> 18475587

Cytokines in clinical and experimental transplantation.

A C Vossen1, H F Savelkoul.   

Abstract

Allograft rejection is a complex process, which requires interactions between different cell types and a variety of soluble factors, such as cytokines. In this review we discuss the role of cytokines in the induction and effector phases of the rejection process and in the induction and maintenance of allospecific graft tolerance. Furthermore, we discuss the feasibility of clinical graft function monitoring by measuring cytokines and the possibilities for intervention in the cytokine network in order to inhibit graft rejection and eventually obtain graft acceptance.

Year:  1994        PMID: 18475587      PMCID: PMC2365586          DOI: 10.1155/S0962935194000566

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  104 in total

1.  T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

Authors:  L A Turka; P S Linsley; H Lin; W Brady; J M Leiden; R Q Wei; M L Gibson; X G Zheng; S Myrdal; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 2.  Molecules involved in T-cell costimulation.

Authors:  M K Jenkins; J G Johnson
Journal:  Curr Opin Immunol       Date:  1993-06       Impact factor: 7.486

Review 3.  T cell co-stimulation and in vivo tolerance.

Authors:  D J Lenschow; J A Bluestone
Journal:  Curr Opin Immunol       Date:  1993-10       Impact factor: 7.486

Review 4.  Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology.

Authors:  B E Bierer; G Holländer; D Fruman; S J Burakoff
Journal:  Curr Opin Immunol       Date:  1993-10       Impact factor: 7.486

5.  The value of plasma-soluble interleukin 2 receptor monitoring in lung transplantation.

Authors:  A D Gascoigne; B K Shenton; M D White; I W Colquhoun; J H Dark; P A Corris
Journal:  Transplantation       Date:  1993-10       Impact factor: 4.939

6.  Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody.

Authors:  M Haak-Frendscho; S A Marsters; J Mordenti; S Brady; N A Gillett; S A Chen; A Ashkenazi
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

7.  Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

Authors:  Y Kita; Y Iwaki; A J Demetris; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

8.  Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse.

Authors:  H Maeda; M Takata; S Takahashi; S Ogoshi; S Fujimoto
Journal:  Int Immunol       Date:  1994-06       Impact factor: 4.823

9.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

Authors:  D J Lenschow; Y Zeng; J R Thistlethwaite; A Montag; W Brady; M G Gibson; P S Linsley; J A Bluestone
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

10.  Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Authors:  H P Brok; P J Heidt; P H van der Meide; C Zurcher; J M Vossen
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

View more
  1 in total

1.  Lymphokine release during co-culture of human lympho-mononuclear cells and fresh or cultured human, porcine and bovine pancreatic islets.

Authors:  R Giannarelli; M Ferdeghini; C Arvia; R Consolini; P Marchetti; A Coppelli; C Prontera; A Legitimo; M Carmellini; F Mosca; R Navalesi
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.